期刊文献+

评WHO肿瘤分类新系列 被引量:3

New series of WHO classification of tumors
下载PDF
导出
摘要 自 2 0 0 0年起 ,WHO肿瘤分类作了重大改变 ,分类的书名改为《肿瘤的病理学和遗传学》 ,新系列将每一类型肿瘤视为一个独立疾病 ,采用了一种新方式进行分类 ,即应用所有的信息 ,包括形态学、免疫表型、遗传学特点、临床表现和影像学技术来定义一种独立疾病。病理科医师、肿瘤科医师与遗传学家应熟悉WHO肿瘤分类新系列 ,该系列提供一个分类的国际标准 。 Since 2000,the new series WHO classification of tumors has been greatly changed. The name of the volumes altered from 《Histological Typing of Tumors》 to 《Pathology and Genetics of Tumors》.The series regards the type of tumor as a disease entity. A new approach to classification has been adopted. In this approach,all available information--morphology,immunophentype,genetic features, clinical features, and imaging features--is used to define a disease entity. Pathologist,oncologists and geneticists should be familiar to the new series WHO classification of tumors. The series provides an international standard. It will serve as an indispensable guide for the design of trials monitoring response to therpy and clinical outcome.
作者 朱雄增
出处 《中国癌症杂志》 CAS CSCD 2001年第5期393-395,共3页 China Oncology
关键词 世界卫生组织 肿瘤 分类 病理学 遗传学 WHO WHO classification of tumors pathology genetics
  • 相关文献

参考文献7

  • 1[1]WHO.WHO Technical Report Series[R].1952,53:45.
  • 2[2]WHO.Manual of the Interational Statistical Classification of Diseases,Injuries, and Causes of Death[M].1975(Geneva).
  • 3[3]WHO. WHO Official Records[M].1956,68:14(Resolution EB17.R40).
  • 4[4]WHO. WHO Official Records[M].1957,79:467(Resolution WHO 18.10).
  • 5[5]WHO. International Classification of Diseases for Oncology[M].1990.
  • 6[6]WHO. College of American Pathologists. Systematized Nomeclature of Medicine[M].1982(Chicago).
  • 7[7]Jaffe ES, Harris NL, Stein H, et al. Pathology and Genetics of Tumours of Haemopoietic and Lymphoid Tissues[M].Lyon:IARC.2001.

同被引文献57

  • 1马琳,刘芙蓉,张淑兰.卵巢癌患者血液中RASSF1A基因甲基化的检测及其意义[J].中华病理学杂志,2005,34(12):785-787. 被引量:8
  • 2董晖,钟丽,孙兴旺.肿瘤DNA甲基化的临床应用进展[J].实用癌症杂志,2007,22(5):527-528. 被引量:2
  • 3Dammann R, Schagdarsurengin U, Seidel C, et al. The tumor suppressor RASSF1 A in human carcinogenesis: an update [ J ]. Histol Histopathol, 2005, 20(2) : 645-663.
  • 4Sekido Y, Ahmadian M, Wistuba II, et al. Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene [ J]. Oncogene, 1998, 16 (24) : 3151-3157.
  • 5Dammann R, Li C, Yoon JH, et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3 p21.3 [ J ]. Nat Genet,2000,25 ( 3 ) :315-319.
  • 6Pfeifer GP, Dammann R. Methylation of the tumor suppressor gene RASSF1A in human tumors[J]. Biochemistry (Mosc) ,2005, 70 (5) : 576-583.
  • 7Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics [ J ]. Trends Genet, 2000,16 (4) : 168- 174.
  • 8Herman JG, Graft JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands [J]. Proc Natl Acad Sci USA, 1996, 93(18) : 9821-9826.
  • 9Hesson LB, Cooper WN, Latif F. The role of RASSF1A methylation in cancer[J]. Dis Markers, 2007, 23(1-2) : 73-87.
  • 10van der Weyden L, Adams DJ. The Ras-association domain family (RASSF) members and their role in human tnmonrigenesis[ J]. Biochim Biophys Acta, 2007, 1776( 1 ) : 58-85.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部